Biological Implants Market to Reach $9.8 Billion by 2024 - Rise in Adoption of Grafts & Organ Substitutes for Reconstructive Surgeries - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Biological Implants Market Size And Forecast By Product, By Application, By Mode Of Administration And Trend Analysis From 2013 To 2024" report to their offering.

Global biological implant market is anticipated to reach USD 9.8 billion by 2024.

Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus affecting industrial growth in the coming years.

North America dominated the market with a revenue share of 50% due to widespread presence of participants coupled with high aesthetic and healthcare awareness levels amongst the population in this region. Asia Pacific is estimated to exhibit the fastest growth in the coming years due to presence of the target population and rapidly improving health care infrastructure which is attributed to drive the demand for tissue engineered products and biological implants.

Companies Mentioned:

  • Integra LifeSciences Corporation
  • NuVasive, Inc
  • Edward LifeSciences Corporation
  • Stryker Corporation
  • LifeCell corporation
  • Medtronic
  • RTI Surgical, Inc
  • BioPolymer GmbH & Co. KG
  • Johnson & Johnson
  • Baxter International, Inc.
  • Vericel Corporation
  • Alphatec Spine, Inc
  • CryoLife
  • Maxigen Biotech, Inc.
  • IOP Ophthalmic Products, Inc.
  • CONMED
  • Allergan Plc
  • BioTissue
  • Auto Tissue Berlin GmbH
  • MiMedx Group, Inc.
  • Organogenesis, Inc.
  • Osiris Therapeutics, Inc.

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Market Variables, Trends& Scope

4 Market Categorization 1: Product Estimates & Trend Analysis

5 Market Categorization 2: Application Estimates & Trend Analysis

6 Market Categorization 3: Mode of administration Estimates & Trend Analysis

7 Market Categorization 4: Regional Estimates & Trend Analysis, by Product & Application

8 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/gwcxfm/biological

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biopharmaceuticals , Biomaterials

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biopharmaceuticals , Biomaterials